1010 Genome, the California based genomics company announced the launch of data analysis services for next generation sequencing applications required by researchers and clinicians involved in research projects and studies.
The Director of Research at 1010 Genome, shared more about the launch of services our expertise and proven experience in offering high speed sequencing data analysis services are now available for all involved in research, clinical and other projects. This is an area that is critical to project heads; to uncover and to validate findings, and this requires not just faster sequencing but data analysis across different applications.
The California Company offers NGS data analysis across platforms including Illumina, Ion Torrent and Pacbio. Both Illumina Data Analysis and Pacbio SMRT Sequencing Data Analysis are acknowledged by industry as methods that offer whole genome sequencing, RNA Seq, structural variation detection and genome assembly applications.
The company caters to the industry by designing and building solutions that help research units and project heads to go from samples to meaningful publishable data in span of days. The company specializes in the development of optimized and customized data analysis workflows that work in tandem with experiments and projects to unearth results.
Metagenomics studies involve sequencing data analysis that require an in depth understanding of the whole process. Genome 1010 has build infrastructure and bioinformatics expertise to generate accurate information on biodiversity and phylogeny. The company has successfully developed in house analysis pipelines that deliver optimal results and low costs.
The development of a new de novo genome and de novo transcriptome assembly protocol has helped the company to generate high quality genome and transcriptome assemblies. With the launch of these services it is expected that research and experiments will get accurate and optimized results that catapult discovery rates.
Source – MENAFN